Four long noncoding RNAs act as biomarkers in lung adenocarcinoma
Lung adenocarcinoma (LUAD) is currently one of the most common malignant tumors worldwide. However, there is a lack of long noncoding RNA (lncRNA)-based effective markers for predicting the prognosis of LUAD patients. We identified four lncRNAs that can effectively predict the prognosis of LUAD pati...
Saved in:
Main Authors: | Zhang Zhihui, Yang Liu, Li Yujiang, Wu Yunfei, Li Xiang, Wu Xu |
---|---|
Format: | article |
Language: | EN |
Published: |
De Gruyter
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/39619bf2fcb44c92a9408a28cc45d87d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lysophosphatidic Acid Receptor 6 (LPAR6) Is a Potential Biomarker Associated with Lung Adenocarcinoma
by: Jian He, et al.
Published: (2021) -
Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
by: Maja Šutić, et al.
Published: (2021) -
CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets
by: Liu F, et al.
Published: (2021) -
Prognostic Implications and Immune Infiltration Analysis of ALDOA in Lung Adenocarcinoma
by: Guojun Lu, et al.
Published: (2021) -
LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma
by: Xin Jin, et al.
Published: (2021)